Trade Mark Journal No.2026/018 1 May 2026

UK00004373671 15 April 2026 (5)

Class 5: Pharmaceutical drugs; Pharmaceuticals; Injectable pharmaceuticals; Anti-diabetic pharmaceuticals; Antidiabetic pharmaceuticals; Medicine; Herbal medicine; Medicine tonics; Medicinal healthcare preparations; Drugs for medical purposes; Astringents [pharmaceutical]; Pharmaceutical preparations for use in oncology; Pharmaceutical compositions; Cardiovascular pharmaceuticals; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals and natural remedies; Pharmaceutical preparations for use in urology; Analgesics for pharmaceutical use; Pharmaceutical preparations; Pharmaceutical preparations for use in dermatology; Dermatological pharmaceutical substances; Pharmaceutical creams; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical implants; Dermatological pharmaceutical products; Pharmaceutical sweets; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations and substances for use in urology; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for use in hematology; Homeopathic pharmaceuticals; Pharmaceutical preparations and substances; Pharmaceutical preparations and substances for use in gynecology; Cardiovascular pharmaceutical preparations; Cytostatics for pharmaceutical purposes; Pharmaceutical preparations for inhalers; Pharmaceutical lipsalves; Alkaloids used for pharmaceutical purposes; Pastilles for pharmaceutical purposes; Bromine for pharmaceutical purposes; Cellulose for pharmaceutical purposes; Menthol for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Alginates for pharmaceutical purposes; Pharmaceutical solutions used in dialysis; Parenteral anti-epileptic pharmaceutical preparations; Esters for pharmaceutical purposes; Food esters for pharmaceutical purposes; Elixirs [pharmaceutical preparations]; Eucalyptol for pharmaceutical purposes; Capsules for pharmaceutical purposes; Lotions for pharmaceutical purposes; Ethanol for pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Pharmaceutical products for the treatment of cancer; Iodine for pharmaceutical purposes; Propolis for pharmaceutical purposes; Chemicals for pharmaceutical use; Anti-bacterial pharmaceutical preparations; Ointments for pharmaceutical purposes; Gentian for pharmaceutical purposes; Pharmaceutical cough preparations; Pharmaceutical preparations for animal skincare; Sandalwood oil for medical, pharmaceutical and veterinary purposes; Phenol for pharmaceutical purposes; Thymol for pharmaceutical purposes; Iodides for pharmaceutical purposes; Alcohol for pharmaceutical purposes; Antibacterials for pharmaceutical use; Pharmaceutical preparations for medical purposes; Pharmaceutical preparations for veterinary use; Alginate tablets for pharmaceutical purposes; Chemical preparations for pharmaceutical purposes; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for use in chemotherapy; Diuretic pharmaceutical preparations; Lactose for pharmaceutical purposes; Pharmaceutical products for the treatment of depression; Lozenges for pharmaceutical purposes; Syrups for pharmaceutical purposes; Phosphates for pharmaceutical purposes; Guaiacol for pharmaceutical purposes; Yeast extracts for medical, veterinary or pharmaceutical purposes; Creosote for pharmaceutical purposes; Pharmaceutical antiallergic preparations and substances; Peptones for pharmaceutical purposes; Aldehydes for pharmaceutical purposes; Oral anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for animals; Malt for pharmaceutical purposes; Pectin for pharmaceutical purposes; Starch for pharmaceutical purposes; Magnesia for pharmaceutical purposes; Perilla for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in the field of anesthesia; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Lupulin for pharmaceutical purposes; Balms for pharmaceutical purposes; Pharmaceutical agents for epidermis; Turpentine for pharmaceutical purposes; Ethers for pharmaceutical purposes; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations for the treatment of osteoporosis; Digestives for pharmaceutical purposes; Tissue-regenerative pharmaceutical preparations; Ergot for pharmaceutical purposes; Cellulose esters for pharmaceutical purposes; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for ophthalmological use; Lime-based pharmaceutical preparations; Synthetic peptides for pharmaceutical purposes; Pharmaceutical preparations for the treatment of cancer; Antibacterial pharmaceuticals; Flaxseed for pharmaceutical purposes; Mustard for pharmaceutical purposes; Yeast for pharmaceutical purposes; Pharmaceutical products and preparations for chloasma; Effervescent analgesic pharmaceutical preparations; Acetates for pharmaceutical purposes; Alginate solutions for pharmaceutical purposes; Starch for dietetic or pharmaceutical purposes; Decoctions for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations and substances for the prevention of cancer.

Read & Simonstone Pharmacy Ltd